Integrated Diagnostics Holdings plc (IDGXF)
Integrated Diagnostics Holdings plc operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Saint Helier, GZ, JE. The stock last traded at $0.60, up 0.00% on the session, giving a market capitalisation of $349.4M. On trailing twelve-month figures it carries a trailing P/E of 9.70, a net margin of 16.5%. Its beta of 0.42 implies it has historically moved less than the broad market.
Integrated Diagnostics Holdings plc (IDHC.L) functions as a leading consumer healthcare enterprise, offering a wide array of medical diagnostic services directly to its clientele. The company's comprehensive service catalog features around 2,000 distinct diagnostic examinations, spanning specialized fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. Geographically, IDHC has established operations across Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, its infrastructure included an extensive network of 452 laboratory branches. The organization was founded in 1979 and maintains its corporate headquarters in Saint Helier, Jersey.